Click to view our statement on Accessibility
Back
Foley Viewpoints

Patenting Risk Evaluation & Mitigation Strategies; For Pharmaceuticals: A New Life Cycle Management Target for Patents?

02 January 2009

Author(s)

Stephen B. Maebius

Partner

Washington, D.C. 202.672.5569

David L. Rosen

Partner

Washington, D.C. 202.672.5430

Judith A. Waltz

Partner

San Francisco 415.438.6412

Related Insights

View All Posts
12 December 2024 Energy Current

IRS Releases Final Regulations Under Section 48 of the Code

The Internal Revenue Service and Department of the Treasury last week released final regulations relating to investment tax credits under Section 48 of the of the Internal Revenue Code.
13 December 2024 Events

Korean Startups & Entrepreneurs: Innovation Weekend

Join Foley & Lardner, the host and sponsor, on December 13th for Day 1 of the KSE Innovation Weekend, dedicated to empowering founders and aspiring entrepreneurs.
08 January 2025 Events

Whistleblower Protections: Navigating Health Care Employment & Labor Rights

Events in our recent history — the COVID-19 pandemic, increase in financial incentives for whistleblowers, and expansion of laws providing whistleblower procedures — have resulted in a spike in the number of whistleblower complaints received by regulators and employers globally.